Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Fight Cancer: Unraveling the pathogenesis to improve treatment of cancer metastasis
Vallet, S. (PI)
01.03.2024 → 28.02.2027
Project: Forschungsimpulse › Research Time Out (RTO)
-
Breast Cancer: Uncovering new checkpoints in natural killer cells to prevent breast cancer metastasis
Witalisz-Siepracka, A. (PI), Vallet, S. (CoPI) & Gotthardt, D. (CoPI)
Gesellschaft für Forschungsförderung NÖ
01.12.2022 → 30.11.2025
Project: Funded Research
-
Untersuchung der Effekte von Immun-Checkpoint Inhibitoren auf den Knochenumbau.
Vallet, S. (PI)
01.11.2021 → 30.11.2023
Project: Forschungsimpulse › Seed Funding
-
BONE: Biomarker- based therapeutic prevention of bone metastases in breast cancer: Defining the pathophysiologic impact of the endosteal niche
Vallet, S. (PI)
01.08.2020 → 31.12.2023
Project: Forschungsimpulse › Research Time Out (RTO)
-
Biomarker: Biomarker- based therapeutic prevention of bone metastases in breast cancer. Defining the pathophysiologic impact of the endosteal niche
Vallet, S. (PI), Podar, K. (CoI) & Wiesner, C. (CoPI)
Gesellschaft für Forschungsförderung NÖ
01.12.2019 → 31.12.2023
Project: Funded Research
Research output
-
Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity
Lind, J., Aksoy, O., Prchal-Murphy, M., Fan, F., Fulciniti, M., Stoiber, D., Bakiri, L., Wagner, E. F., Zwickl-Traxler, E., Sattler, M., Kollmann, K., Vallet, S. & Podar, K., 19 Aug 2024, In: Blood Cancer Journal. 14, 1, 138.Research output: Journal article (peer-reviewed) › Journal article
Open Access1 Citation (Scopus) -
Favorable impact of PD1/PD-L1 antagonists on bone remodeling: an exploratory prospective clinical study and ex vivo validation
Gassner, T., Chittilappilly, C., Pirich, T., Neuditschko, B., Hackner, K., Lind, J., Aksoy, O., Graichen, U., Klee, S., Herzog, F., Wiesner, C., Errhalt, P., Pecherstorfer, M., Podar, K. & Vallet, S., 03 May 2024, In: Journal for ImmunoTherapy of Cancer. 12, 5, e008669.Research output: Journal article (peer-reviewed) › Journal article
Open Access2 Citations (Scopus) -
Real-world Evidence for Enfortumab Vedotin in Patients with Metastatic Urothelial Cancer: An Austrian Multicentre Study
Niedersuess-Beke, D., Mayrhofer, K., Krauter, J., Schnabel, S., Gampenrieder, S. P., Miechowiecki, J., Kiesl, D., Luger, F., Pfuner, J., Wiesinger, C., Vallet, S., Andalibi, H., Vais, D., Banner, A., Stoiber, F., Spielgelberg, J., Barth, D., Bauernhofer, T., Aufderklamm, S. & Weibrecht, S. & 9 others, , 22 Nov 2024, (E-pub ahead of print) In: Clinical Genitourinary Cancer. p. 102278 102278.Research output: Journal article (peer-reviewed) › Journal article
Open Access -
Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter Study
Kafka, M., Giannini, G., Artamonova, N., Neuwirt, H., Ofner, H., Kramer, G., Bauernhofer, T., Luger, F., Höfner, T., Loidl, W., Griessner, H., Lusuardi, L., Bergmaier, A., Berger, A., Winder, T., Weiss, S., Bauinger, S., Krause, S., Drerup, M. & Heinrich, E. & 17 others, , Apr 2024, In: Clinical Genitourinary Cancer. 22, 2, p. 458-466.e1Research output: Journal article (peer-reviewed) › Journal article
Open Access4 Citations (Scopus) -
Bone marrow microenvironment- induced regulation of Bcl-2 family members in multiple myeloma (MM): Therapeutic implications
Aksoy, O., Lind, J., Sunder-Plaßmann, V., Vallet, S. & Podar, K., Jan 2023, In: Cytokine. 161, p. 156062 156062.Research output: Journal article (peer-reviewed) › Journal article
Open Access6 Citations (Scopus)
Prizes
-
Wissenschaftspreis des Landes Niederösterreich 2022
Vallet, S. (Recipient), 2022
Prize: Honorary award
Activities
- 3 Membership
-
-
European Society for Medical Oncology (External organisation)
Vallet, S. (Member)
2022 → …Activity: Membership
-
Österreichische Gesellschaft für Hämatologie & Medizinische Onkologie (OeGHO) (External organisation)
Vallet, S. (Member)
2022Activity: Membership